Consensus on early detection of disease progression in patients with multiple sclerosis

Consensus on early detection of disease progression in patients with multiple sclerosis

BackgroundEarly identification of the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) can be challenging for clinicians, as diagnostic criteria for SPMS are primarily based on physical disability and a holistic interpretation.ObjectiveTo establish a c...

Full description

Bibliographic Details
Main Authors:	José E. Meca-Lallana, Bonaventura Casanova, Alfredo Rodríguez-Antigüedad, Sara Eichau, Guillermo Izquierdo, Carmen Durán, Jordi Río, Miguel Ángel Hernández, Carmen Calles, José M. Prieto-González, José Ramón Ara, Dionisio F. Uría, Lucienne Costa-Frossard, Antonio García-Merino, Celia Oreja-Guevara
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Neurology
Subjects:	multiple sclerosis early detection secondary progressive multiple sclerosis consensus disease progression
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.931014/full

Similar Items

Consensus for the Early Identification of Secondary Progressive Multiple Sclerosis in Portugal: a Delphi Panel
by: Maria José Sá, et al.
Published: (2023-02-01)

Deciphering Multiple Sclerosis Progression
by: Virginia Meca-Lallana, et al.
Published: (2021-04-01)

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
by: Francisco Gascón-Giménez, et al.
Published: (2023-03-01)

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español
by: S. Otero-Romero, et al.
Published: (2021-01-01)

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
by: Francisco Carlos Pérez‐Miralles, et al.
Published: (2021-04-01)

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
by: Ethel Ciampi, et al.
Published: (2020-05-01)

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021
by: Crystal Watson, et al.
Published: (2023-09-01)

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study
by: Ambra Mara Giovannetti, et al.
Published: (2020-08-01)

Malignant multiple sclerosis: clinical and demographic prognostic factors
by: Fabrício Hampshire-Araújo, et al.

Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis
by: Ya. V. Vlasov, et al.
Published: (2021-09-01)

Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms
by: Ayache SS, et al.
Published: (2016-05-01)

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
by: Vermersch Patrick, et al.
Published: (2012-06-01)

Should We Use Clinical Tools to Identify Disease Progression?
by: Hernan Inojosa, et al.
Published: (2021-01-01)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients—The Example of Croatia
by: Ana Jerković, et al.
Published: (2022-07-01)

Rehabilitation of patients with progressive forms of multiple sclerosis
by: S. A. Sivertseva, et al.
Published: (2022-08-01)

Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil
by: Vijayalakshmi Vasanthaprasad, et al.
Published: (2022-08-01)

Pathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells
by: Chenyang Zhang, et al.
Published: (2023-03-01)

OCRELIZUMAB IN THE TREATMENT OF PRIMARY-PROGRESSIVE MULTIPLE SCLEROSIS
by: E. V. Popova
Published: (2018-02-01)

Clinical characteristics of multiple sclerosis in the Tomsk region
by: V M Alifirova, et al.
Published: (2012-06-01)

New possibilities for the therapy of secondary progressive multiple sclerosis
by: A. M. Petrov, et al.
Published: (2019-12-01)

Progression of Relapsing-Remitting Multiple Sclerosis despite the new era of treatments
by: Gutemberg Augusto Cruz dos Santos, et al.
Published: (2022-12-01)

The Importance of Cerebellar Involvement in Identifying the Prognosis in Patients with Progressive Multiple Sclerosis
by: Egemen İdiman, et al.
Published: (2004-04-01)

Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis
by: Gholamali Yousefipour, et al.
Published: (2016-06-01)

Changes in retinal structures as markers of multiple sclerosis progression
by: M. O. Poplyak, et al.
Published: (2021-12-01)

Treatment of relapsing multiple sclerosis in Hungary – consensus recommendation from the Hungarian neuroimmunology society
by: Cecilia Rajda, et al.
Published: (2023-07-01)

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
by: Vanessa Daccach Marques, et al.

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis
by: Mostafa Almasi, et al.
Published: (2021-01-01)

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis
by: D. S. Kasatkin, et al.
Published: (2021-02-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
by: Katharina Breitkopf, et al.
Published: (2020-08-01)

Long-Term Disability Outcomes in Relapsing–Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
by: Laura Barcutean, et al.
Published: (2024-03-01)

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
by: N. V. Khachanova, et al.
Published: (2019-12-01)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
by: Jiwon Oh, et al.
Published: (2021-10-01)

Comparing power and activity of lower body muscles in two types of multiple sclerosis patients and healthy individuals
by: Talebi V, et al.
Published: (2020-05-01)

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases
by: Priyadarshi Prajjwal, et al.
Published: (2023-07-01)

Linear Modeling of Multiple Sclerosis and Its Subgroubs
by: Yeliz Karaca, et al.
Published: (2015-03-01)

How to estimate the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis? (ORP-43)
by: Sepideh Paybast
Published: (2023-01-01)

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
by: Katarzyna Kapica-Topczewska, et al.
Published: (2021-02-01)